<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="bf3007e2-8fcc-48de-8fd5-55e95033d62f"><labelDrug name="Vaseretic"><Normalization><mmtx cui="C0633761" preferredWord="Vaseretic" semType="phsu, orch"/></Normalization></labelDrug><generic name="enalapril maleate and hydrochlorothiazide"/><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.1" text="VASERETIC (enalapril maleate and hydrochlorothiazide) tablet" type="negative"><entity charOffset="33:52" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.1.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="11:28" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.1.e.1" text="enalapril maleate" type="Biomedical_Entity"><Normalization><mmtx cui="C0700452" phraseText="(enalapril maleate" preferredWord="Enalapril Maleate" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.1.e.2" text="vaseretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0633761" phraseText="VASERETIC" preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.1.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.1.e.0"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.1.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.1.e.0"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.1.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.1.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.3" text="VASERETIC is contraindicated in patients who are hypersensitive to any component of this product and in patients with a history of angioedema related to previous treatment with an angiotensin converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema. " type="negative"><entity charOffset="180:219" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.3.e.0" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="with an angiotensin converting enzyme inhibitor" preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.3.e.1" text="vaseretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0633761" phraseText="VASERETIC" preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.3.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.3.e.0"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.4" text="Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs." type="negative"><entity charOffset="131:142" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.4.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="hypersensitivity to other sulfonamide-derived drugs." preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="15:34" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.4.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Because of the hydrochlorothiazide component," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.4.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.4.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5" lineNumber="7" text="Do not coadminister aliskiren with VASERETIC in patients with diabetes (see PRECAUTIONS, Drug Interactions)." type="regular"><entity charOffset="20:29" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with VASERETIC" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="35:44" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.1" text="VASERETIC" type="Drug"><Normalization><mmtx cui="C0633761" phraseText="aliskiren with VASERETIC" preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><entity charOffset="62:70" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.2" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.3" text="Do not coadminister" type="Caution_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.3"><relations><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.2" ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.1" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.5.e.3" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9" lineNumber="15" text="Hypotension: Excessive hypotension was rarely seen in uncomplicated hypertensive patients but is a possible consequence of enalapril use in severely salt/volume depleted persons such as those treated vigorously with diuretics or patients on dialysis." type="regular"><entity charOffset="23:34" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.0" text="hypotension" type="Specific_Interaction"/><entity charOffset="123:132" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.2" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="a possible consequence of enalapril use" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="149:177" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.3" text="salt/volume depleted persons" type="SPAN"/><entity charOffset="216:225" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.4" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="with diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.0"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.3" ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.4" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.9.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.15" text="Such patients should be followed closely for the first two weeks of treatment and whenever the dose of enalapril and/or diuretic is increased. " type="negative"><entity charOffset="103:112" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.15.e.0" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="the dose of enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="120:128" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.15.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.15.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.15.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.20" text="Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including VASERETIC) may be subject to a variety of adverse reactions, some of them serious." type="negative"><entity charOffset="193:202" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.20.e.0" text="vaseretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0633761" phraseText="VASERETIC" preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><entity charOffset="19:59" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.20.e.1" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="angiotensin-converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="167:181" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.20.e.2" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.20.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.20.e.0"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.20.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.20.e.0"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.21" text="Head and Neck Angioedema: Angioedema of the face, extremities, lips, tongue, glottis and/or larynx has been reported in patients treated with angiotensin converting enzyme inhibitors, including enalapril. " type="negative"><entity charOffset="142:182" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.21.e.0" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treated with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="194:203" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.21.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="enalapril." preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.21.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.21.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.30" text="The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor. " type="negative"><entity charOffset="142:155" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.30.e.0" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="129:137" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.30.e.1" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="resolved after stopping" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.30.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.30.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33" lineNumber="33" text="Anaphylactoid reactions during desensitization: Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions. " type="regular"><entity charOffset="48:60" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.0" text="Two patients" type="SPAN"/><entity charOffset="101:118" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.1" text="hymenoptera venom" type="Substance"><Normalization><mmtx cui="C1290000" phraseText="desensitizing treatment with hymenoptera venom" preferredWord="Hymenoptera venom" semType="phsu"/><RxNorm RxCui="390053"/></Normalization></entity><entity charOffset="135:149" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.2" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="receiving ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="177:200" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.3" text="anaphylactoid reactions" type="Specific_Interaction"/><entity charOffset="160:176" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.5" text="life-threatening" type="SPAN"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.0"/></relation><relation type="hasSeverity"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.0" ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.2" severity="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.5" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.33.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.37" text="Neutropenia/Agranulocytosis: Another angiotensin converting enzyme inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression, rarely in uncomplicated patients but more frequently in patients with renal impairment especially if they also have a collagen vascular disease. " type="negative"><entity charOffset="78:87" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.37.e.0" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="captopril," preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><entity charOffset="37:76" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.37.e.1" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="Another angiotensin converting enzyme inhibitor," preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.37.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.37.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51" lineNumber="51" text="Lithium generally should not be given with thiazides (see PRECAUTIONS, Drug Interactions, Enalapril Maleate and Hydrochlorothiazide)." type="regular"><entity charOffset="0:7" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51.e.0" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="43:52" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51.e.1" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="given with thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="25:37" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51.e.2" text="not be given" type="Caution_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51.e.1" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.51.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.53" text="Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="23:34" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.53.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="a sulfonamide," preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.53.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.53.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.53.e.0"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.67" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="168:179" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.67.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="198:221" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.67.e.1" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.67.e.2" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.67.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.67.e.1"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.67.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.67.e.0"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.78" text="There was no teratogenicity in mice given up to 30 mg/kg/day or in rats given up to 90 mg/kg/day of enalapril in combination with 10 mg/kg/day of hydrochlorothiazide. " type="negative"><entity charOffset="146:165" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.78.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="of hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="100:109" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.78.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="given up to 90 mg/kg/day of enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.78.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.78.e.0"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.79" text="These doses of enalapril are 4.3 and 26 times (mice and rats, respectively) the maximum recommended human daily dose (MRHDD) when compared on a body surface area basis (mg/m2); " type="negative"><entity charOffset="15:24" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.79.e.0" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="These doses of enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="162:167" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.79.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="compared on a body surface area basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.79.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.79.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.83" text="30/10 mg/kg/day of enalapril-hydrochlorothiazide in rats and 10/10 mg/kg/day of enalapril-hydrochlorothiazide in mice." type="negative"><entity charOffset="80:109" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.83.e.0" text="enalapril-hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717738" phraseText="10/10 mg/kg/day of enalapril-hydrochlorothiazide" preferredWord="Enalapril / Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="214536"/></Normalization></entity><entity charOffset="19:28" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.83.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="30/10 mg/kg/day of enalapril-hydrochlorothiazide" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="0:48" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.83.e.2" text="30 mg hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0986527" phraseText="30/10 mg/kg/day of enalapril-hydrochlorothiazide" preferredWord="Hydrochlorothiazide 30 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.83.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.83.e.0"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.83.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.83.e.0"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.83.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.83.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.85" text="When pregnancy is detected, VASERETIC should be discontinued as soon as possible (see Enalapril Maleate, Fetal Toxicity)." type="negative"><entity charOffset="86:103" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.85.e.0" text="enalapril maleate" type="Biomedical_Entity"><Normalization><mmtx cui="C0700452" phraseText="Enalapril Maleate," preferredWord="Enalapril Maleate" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="28:37" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.85.e.1" text="vaseretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0633761" phraseText="VASERETIC" preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.85.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.85.e.0"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.94" text="Aortic Stenosis/Hypertrophic Cardiomyopathy: As with all vasodilators, enalapril should be given with caution to patients with obstruction in the outflow tract of the left ventricle." type="negative"><entity charOffset="57:69" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.94.e.0" text="vasodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="As with all vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="71:80" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.94.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.94.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.94.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.95" text="Impaired Renal Function: As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals. " type="negative"><entity charOffset="66:77" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.95.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:89" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.95.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.95.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.95.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.96" text="In patients with severe congestive heart failure whose renal function may depend on the activity of the renin-angiotensin-aldersterone system, treatment with angiotensin converting enzyme inhibitors, including enalapril, may be associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death (see PRECAUTIONS, Drug Interactions)." type="negative"><entity charOffset="110:121" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.96.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldersterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="158:198" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.96.e.1" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="210:219" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.96.e.2" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="enalapril," preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.96.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.96.e.1"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.96.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.96.e.2"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.96.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.96.e.2"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.98" text="These increases were almost always reversible upon discontinuation of enalapril and/or diuretic therapy. " type="negative"><entity charOffset="87:95" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.98.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic therapy." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="70:79" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.98.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="almost always reversible upon discontinuation of enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.98.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.98.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100" lineNumber="91" text="Some patients with hypertension or heart failure with no apparent pre-existing renal vascular disease have developed increases in blood urea and serum creatinine, usually minor and transient, especially when enalapril has been given concomitantly with a diuretic. " type="regular"><entity charOffset="208:217" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.0" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="254:262" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.1" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="concomitantly with a diuretic." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="19:101" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.2" text="hypertension or heart failure with no apparent pre-existing renal vascular disease" type="SPAN"><Normalization><mmtx cui="C0020538" phraseText="Some patients with hypertension" preferredWord="Hypertensive disease" semType="dsyn"/><mmtx cui="C0018801" phraseText="heart failure with no apparent pre-existing renal vascular disease" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0268790" phraseText="heart failure with no apparent pre-existing renal vascular disease" preferredWord="Renal vascular disorder" semType="dsyn"/><mmtx cui="C0018802" phraseText="heart failure with no apparent pre-existing renal vascular disease" preferredWord="Congestive heart failure" semType="dsyn"/><mmtx cui="C0268790" phraseText="heart failure with no apparent pre-existing renal vascular disease" preferredWord="Renal vascular disorder" semType="dsyn"/></Normalization></entity><entity charOffset="117:140" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.3" text="increases in blood urea" type="Specific_Interaction"/><entity charOffset="117:129|145:161" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.5" text="increases in serum creatinine" type="Specific_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.3"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.ddi.2"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.5"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.2" ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.1" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.100.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.102" text="Dosage reduction of enalapril and/or discontinuation of the diuretic may be required." type="negative"><entity charOffset="60:68" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.102.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="discontinuation of the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="20:29" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.102.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="Dosage reduction of enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.102.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.102.e.0"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.104" text="Hyperkalemia: Elevated serum potassium (greater than 5.7 mEq/L) was observed in approximately one percent of hypertensive patients in clinical trials treated with enalapril alone. " type="negative"><entity charOffset="29:38" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.104.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="Elevated serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="163:172" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.104.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="treated with enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.104.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.104.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107" lineNumber="95" text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes, which should be used cautiously, if at all, with enalapril (see Drug Interactions)." type="regular"><entity charOffset="36:48" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.0" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="270:279" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.2" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="with enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="124:151" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.3" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="the concomitant use of potassium-sparing diuretics," preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="153:174" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.4" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="182:219" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.5" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes," preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes," preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.4" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.2" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.5" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.2" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.3" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.2" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.4" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.5"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.3" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.4"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.3" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.107.e.5"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110" lineNumber="99" text="Surgery/Anesthesia: In patients undergoing major surgery or during anesthesia with agents that produce hypotension, enalapril may block angiotensin II formation secondary to compensatory renin release. " type="regular"><entity charOffset="67:114" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110.e.0" text="anesthesia with agents that produce hypotension" type="Drug_Class"><Normalization><mmtx cui="C0002932" phraseText="or during anesthesia" preferredWord="Anesthetics" semType="phsu"/><mmtx cui="C1254351" phraseText="with agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="1021939"/></Normalization></entity><entity charOffset="116:125" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110.e.1" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="130:160" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110.e.2" text="block angiotensin II formation" type="Specific_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110.e.1" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.110.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.113" text="Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals. " type="negative"><entity charOffset="32:44" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.113.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="Periodic determination of serum electrolytes to" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="64:75" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.113.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="possible electrolyte imbalance" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.113.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.113.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.114" text="All patients receiving thiazide therapy should be observed for clinical signs of fluid or electrolyte imbalance: hyponatremia, hypochloremic alkalosis, and hypokalemia. " type="negative"><entity charOffset="90:101" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.114.e.0" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="electrolyte imbalance" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="23:31" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.114.e.1" text="thiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="thiazide therapy" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.114.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.114.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120" lineNumber="105" text="Because enalapril reduces the production of aldosterone, concomitant therapy with enalapril attenuates the diuretic-induced potassium loss (see Drug Interactions, Agents Increasing Serum Potassium)." type="regular"><entity charOffset="82:91" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120.e.0" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="concomitant therapy with enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="107:115" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120.e.1" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0354170" phraseText="the diuretic-induced potassium loss" preferredWord="Diuretics with potassium" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="92:102|124:138" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120.e.2" text="attenuates potassium loss" type="Specific_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120.e.1" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.120.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126" lineNumber="113" text="In diabetic patients dosage adjustments of insulin or oral hypoglycemic agents may be required. " type="irregular"><entity charOffset="43:50" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.0" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="of insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="of insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="of insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="54:78" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.1" text="oral hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="3:20" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.2" text="diabetic patients" type="SPAN"/><entity charOffset="21:39" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.3" text="dosage adjustments" type="Caution_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.3"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.125" text="Hyperuricemia may occur or frank gout may be precipitated in certain patients receiving thiazide therapy."><entity charOffset="88:96" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.125.e.0" text="thiazide" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="thiazide therapy." preferredWord="Thiazides" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.126.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.133" text="Thiazides may decrease urinary calcium excretion. " type="negative"><entity charOffset="31:38" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.133.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="urinary calcium excretion." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.133.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.133.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.133.e.0"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.134" text="Thiazides may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. " type="negative"><entity charOffset="0:9" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.134.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="63:70" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.134.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="slight elevation of serum calcium" preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.134.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.134.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.139" text="Angioedema: Angioedema, including laryngeal edema, may occur at any time during treatment with angiotensin converting enzyme inhibitors, including enalapril. " type="negative"><entity charOffset="147:156" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.139.e.0" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="enalapril." preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="95:135" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.139.e.1" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.139.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.139.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.146" lineNumber="133" text="Hyperkalemia: Patients should be told not to use salt substitutes containing potassium without consulting their physician." type="irregular"><entity charOffset="49:86" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.146.e.0" text="salt substitutes containing potassium" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><mmtx cui="C0597277" phraseText="potassium without consulting" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><entity charOffset="38:48" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.146.e.1" text="not to use" type="Caution_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.146.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.146.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.146.e.0"/></relation><relation type="hasObject"><labelDrug text="Vaseretic"/><normalization><mmtx><preferredWord>Vaseretic</preferredWord><phraseText>aliskiren with VASERETIC</phraseText><cuiCode>C0633761</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.146.e.0"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.156" text="Dual Blockade of the Renin-Angiotensin System (RAS)" type="negative"><entity charOffset="5:13" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.156.e.0" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.156.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.156.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.156.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157" lineNumber="147" text="Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="regular"><entity charOffset="61:75" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.1" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="128:139" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.2" text="hypotension" type="Specific_Interaction"/><entity charOffset="141:153" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.4" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.6" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.8" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.155.e.0" drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.0"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.ddi.2"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.ddi.3"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.ddi.4"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.1" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.157.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158" lineNumber="147" text="Closely monitor blood pressure, renal function, and electrolytes in patients on VASERETIC and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="80:89" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158.e.2" text="VASERETIC" type="Drug"><Normalization><mmtx cui="C0633761" phraseText="on VASERETIC" preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><entity charOffset="100:126" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158.e.3" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.158.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159" lineNumber="149" text="Do not coadminister aliskiren with VASERETIC in patients with diabetes. " type="regular"><entity charOffset="0:19" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.0" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="20:29" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with VASERETIC" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="35:44" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.3" text="VASERETIC" type="Drug"><Normalization><mmtx cui="C0633761" phraseText="aliskiren with VASERETIC" preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><entity charOffset="62:70" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.0"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.4" ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.3" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.159.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160" lineNumber="149" text="Avoid use of aliskiren with VASERETIC in patients with renal impairment (GFR &lt;60 mL/min." type="regular"><entity charOffset="0:5" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:37" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.3" text="VASERETIC" type="Drug"><Normalization><mmtx cui="C0633761" phraseText="with VASERETIC" preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><entity charOffset="55:71" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.0"><relations><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.4" ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.3" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.160.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161" lineNumber="151" text="Hypotension   Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril. " type="regular"><entity charOffset="239:248" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161.e.0" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="with enalapril." preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="56:65" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161.e.1" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Patients on diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="178:205" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161.e.2" text="reduction of blood pressure" type="Specific_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161.e.2"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161.e.0" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.161.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.162" text="The possibility of hypotensive effects with enalapril can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril. " type="negative"><entity charOffset="44:53" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.162.e.0" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="with enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="99:107" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.162.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="176:185" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.162.e.2" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="with enalapril." preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.162.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.162.e.1"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.162.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.162.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164" lineNumber="153" text="Agents Causing Renin Release: The antihypertensive effect of enalapril is augmented by antihypertensive agents that cause renin release (e.g., diuretics)." type="regular"><entity charOffset="61:70" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.0" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="The antihypertensive effect of enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="87:135" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.1" text="antihypertensive agents that cause renin release" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="augmented by antihypertensive agents" preferredWord="Antihypertensive Agents" semType="phsu"/><mmtx cui="C0035100" phraseText="renin release" preferredWord="Chymosin" semType="phsu, aapp, enzy"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="143:152" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.2" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="34:57|71:83" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.4" text="antihypertensive effect is augmented" type="Specific_Interaction"/><classClassMembership drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.2"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.4"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.1" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.164.e.4" type="Specific_Interaction"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.165" text="Non-steroidal Anti-inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)" type="negative"><entity charOffset="0:38" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.165.e.0" text="non-steroidal anti-inflammatory agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="Non-steroidal Anti-inflammatory Agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="88:104" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.165.e.1" text="cox-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="(COX-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="382306"/></Normalization></entity><entity charOffset="59:86" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.165.e.2" text="cyclooxygenase-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="Selective Cyclooxygenase-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="119049"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.165.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.165.e.1"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.165.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.165.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166" lineNumber="157" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including enalapril, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="141:147" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.0" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="159:185" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.1" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="192:206" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.3" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="218:227" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.4" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="enalapril," preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="20:27" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.6" text="elderly" type="SPAN"/><entity charOffset="29:44" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.7" text="volume-depleted" type="SPAN"/><entity charOffset="92:118" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.8" text="compromised renal function" type="SPAN"/><entity charOffset="243:274" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.9" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="295:314" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.11" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.1"/><drugClassMembership drug="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.4" drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.3"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.9"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.7"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.8"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.ddi.2"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.11"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.7"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.8"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.7, Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.6, Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.8" ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.3" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.166.e.9" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168" lineNumber="157" text="Monitor renal function periodically in patients receiving enalapril and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:67" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168.e.2" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="72:77" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168.e.3" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.168.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.169" text="In a clinical pharmacology study, indomethacin or sulindac was administered to hypertensive patients receiving enalapril maleate. " type="negative"><entity charOffset="111:128" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.169.e.0" text="enalapril maleate" type="Biomedical_Entity"><Normalization><mmtx cui="C0700452" phraseText="enalapril maleate." preferredWord="Enalapril Maleate" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="34:46" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.169.e.1" text="indomethacin" type="Biomedical_Entity"><Normalization><mmtx cui="C0021246" phraseText="indomethacin" preferredWord="Indomethacin" semType="phsu, orch"/><RxNorm RxCui="5781"/></Normalization></entity><entity charOffset="50:58" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.169.e.2" text="sulindac" type="Biomedical_Entity"><Normalization><mmtx cui="C0038792" phraseText="sulindac" preferredWord="Sulindac" semType="phsu, orch"/><RxNorm RxCui="10237"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.169.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.169.e.0"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.169.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.169.e.0"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.169.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.169.e.2"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.170" text="In this study there was no evidence of a blunting of the antihypertensive action of enalapril maleate. " type="negative"><entity charOffset="57:73" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.170.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="no evidence of a blunting of the antihypertensive action of enalapril maleate." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="84:101" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.170.e.1" text="enalapril maleate" type="Biomedical_Entity"><Normalization><mmtx cui="C0700452" phraseText="no evidence of a blunting of the antihypertensive action of enalapril maleate." preferredWord="Enalapril Maleate" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.170.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.170.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171" lineNumber="159" text="However, reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors." type="regular"><entity charOffset="30:36" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171.e.0" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="that NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="81:95" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="the antihypertensive effect of ACE inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="41:77" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171.e.2" text="diminish the antihypertensive effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171.e.1" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.171.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172" text="Other Cardiovascular Agents: Enalapril has been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine and prazosin without evidence of clinically significant adverse interactions." type="negative"><entity charOffset="29:38" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.0" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="Enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="127:134" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="calcium-blocking agents," preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="105:115" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.2" text="methyldopa" type="Biomedical_Entity"><Normalization><mmtx cui="C0025741" phraseText="methyldopa," preferredWord="Methyldopa" semType="phsu, aapp, nsba"/><RxNorm RxCui="6876"/></Normalization></entity><entity charOffset="72:103" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.3" text="beta adrenergic-blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="concomitantly with beta adrenergic-blocking agents," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="6:27" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.4" text="cardiovascular agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0007220" phraseText="Other Cardiovascular Agents" preferredWord="Cardiovascular Agents" semType="phsu"/><RxNorm RxCui="1021827"/></Normalization></entity><entity charOffset="152:163" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.5" text="hydralazine" type="Biomedical_Entity"><Normalization><mmtx cui="C0020223" phraseText="hydralazine" preferredWord="Hydralazine" semType="phsu, orch"/><RxNorm RxCui="5470"/></Normalization></entity><entity charOffset="168:176" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.6" text="prazosin" type="Biomedical_Entity"><Normalization><mmtx cui="C0032912" phraseText="prazosin without evidence of clinically significant adverse interactions." preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.1"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.2"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.3"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.4" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.0"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.5"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.6"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.1"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.3" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.1"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.4" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.1"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.5"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.6"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.3" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.2"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.4" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.2"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.5"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.6"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.4" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.3"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.3" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.5"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.3" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.6"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.4" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.5"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.4" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.6"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.5" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.172.e.6"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173" lineNumber="163" text="Agents Increasing Serium Potassium: Enalapril attenuates diuretic-induced potassium loss. " type="regular"><entity charOffset="36:45" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.0" text="Enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="Enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="57:65" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.1" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0354170" phraseText="diuretic-induced potassium loss." preferredWord="Diuretics with potassium" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="46:56|74:88" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.2" text="attenuates potassium loss" type="Specific_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.2"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.1" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="6" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174" lineNumber="163" text="Potassium-sparing diuretics (e.g., spironolactone, triameterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. " type="irregular"><entity charOffset="0:27" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.0" text="Potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="Potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="35:49" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.1" text="spironolactone" type="Drug"><Normalization><mmtx cui="C0037982" phraseText="spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="51:63" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.2" text="triameterene" type="Drug"><Normalization><RxNorm RxCui="314029"/></Normalization></entity><entity charOffset="68:77" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.3" text="amiloride" type="Drug"><Normalization><mmtx cui="C0002502" phraseText="amiloride" preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="80:101" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.7" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="106:143" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.8" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="168:196" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.9" text="increases in serum potassium" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.1" drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.0"/><drugClassMembership drug="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.2" drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.0"/><drugClassMembership drug="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.3" drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.0"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.9"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173" text="Agents Increasing Serium Potassium: Enalapril attenuates diuretic-induced potassium loss. "><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.0"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.7" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.8"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.8"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.7"/><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.8"/><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.7"/><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.0"/></sentence><sentence biomedicalEntities="0" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175" lineNumber="163" text="Therefore, if concomitant use of these agents is indicated because of demonstrated hypokalemia they should be used with caution and with frequent monitoring of serum potassium." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174" Text="Potassium-sparing diuretics (e.g., spironolactone, triameterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "/><anaphoraEntity charOffset="33:45" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.e.2" text="these agents" type="Expression"/><antecedentEntity charOffset="0:27" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.0" text="Potassium-sparing diuretics" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174" Text="Potassium-sparing diuretics (e.g., spironolactone, triameterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "/><anaphoraEntity charOffset="33:45" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.e.2" text="these agents" type="Expression"/><antecedentEntity charOffset="80:101" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.7" text="potassium supplements" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174" Text="Potassium-sparing diuretics (e.g., spironolactone, triameterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "/><anaphoraEntity charOffset="33:45" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.e.2" text="these agents" type="Expression"/><antecedentEntity charOffset="106:143" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174.e.8" text="potassium-containing salt substitutes" type="Substance"/></anaphoraRelation><entity charOffset="110:127" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.e.0" text="used with caution" type="Caution_Interaction"/><entity charOffset="146:156" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.e.6" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173" text="Agents Increasing Serium Potassium: Enalapril attenuates diuretic-induced potassium loss. "><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.0"/></ellipsisSentence><middleSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174" text="Potassium-sparing diuretics (e.g., spironolactone, triameterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.ddi.2"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173" text="Agents Increasing Serium Potassium: Enalapril attenuates diuretic-induced potassium loss. "><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.173.e.0"/></ellipsisSentence><middleSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.174" text="Potassium-sparing diuretics (e.g., spironolactone, triameterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.175.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176" lineNumber="165" text="Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors. " type="regular"><entity charOffset="93:132" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.0" text="drugs which cause elimination of sodium" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="lithium concomitantly with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0597484" phraseText="elimination of sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="144:158" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="17:25" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.3" text="toxicity" type="Increase_Interaction"/><entity charOffset="9:16" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.5" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><classClassMembership drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.1"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.5" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.0" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.176.e.3" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177" lineNumber="165" text="A few cases of lithium toxicity have been reported in patients receiving concomitant enalapril and lithium and were reversible upon discontinuation of both drugs. " type="regular"><entity charOffset="2:11" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.0" text="few cases" type="SPAN"/><entity charOffset="85:94" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.1" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="concomitant enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="15:22" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="A few cases of lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="23:31" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.3" text="toxicity" type="Increase_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.2"/></relation><relation type="hasEvidence"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.1" evidence="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.0" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.177.e.3" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178" lineNumber="165" text="It is recommended that serum lithium levels be monitored frequently if enalapril is administered concomitantly with lithium." type="regular"><entity charOffset="47:56" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178.e.0" text="monitored" type="Caution_Interaction"/><entity charOffset="71:80" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178.e.2" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="116:123" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="concomitantly with lithium." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178.e.3" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.178.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179" lineNumber="167" text="Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including VASERETIC." type="regular"><entity charOffset="6:25" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.0" text="Nitritoid reactions" type="Specific_Interaction"><Normalization><mmtx cui="C0948404" phraseText="Nitritoid reactions" preferredWord="Nitritoid reaction" semType="dsyn"/></Normalization></entity><entity charOffset="44:59" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.2" text="facial flushing" type="Specific_Interaction"><Normalization><mmtx cui="C0016382" phraseText="facial flushing," preferredWord="Flushing" semType="sosy"/></Normalization></entity><entity charOffset="61:67" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.4" text="nausea" type="Specific_Interaction"><Normalization><mmtx cui="C0027497" phraseText="nausea," preferredWord="Nausea" semType="sosy"/></Normalization></entity><entity charOffset="69:77" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.6" text="vomiting" type="Specific_Interaction"><Normalization><mmtx cui="C0042963" phraseText="vomiting" preferredWord="Vomiting" semType="sosy"/></Normalization></entity><entity charOffset="82:93" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.8" text="hypotension" type="Specific_Interaction"/><entity charOffset="166:187" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.10" text="sodium aurothiomalate" type="Drug"><Normalization><mmtx cui="C0018034" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold Sodium Thiomalate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="205:218" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.11" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="concomitant ACE inhibitor therapy" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="237:246" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.12" text="VASERETIC" type="Drug"><Normalization><mmtx cui="C0633761" phraseText="VASERETIC." preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><drugClassMembership drug="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.12" drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.11"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.0"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.ddi.2"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.2"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.ddi.3"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.4"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.ddi.4"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.6"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.ddi.5"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.8"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.10"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.10" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.11" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.179.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182" lineNumber="173" text="Alcohol, barbiturates, or narcotics   potentiation of orthostatic hypotension may occur." type="irregular"><entity charOffset="38:77" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.0" text="potentiation of orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="narcotics   potentiation of orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.2" text="Alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="Alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="9:21" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.3" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.4" text="narcotics" type="Drug_Class"><Normalization><mmtx cui="C0027415" phraseText="narcotics   potentiation of orthostatic hypotension" preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.181" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.181.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.4"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.3"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.3" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183" lineNumber="175" text="Antidiabetic drugs (oral agents and insulin)   dosage adjustment of the antidiabetic drug may be required." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="72:89" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.e.4" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="0-31" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.e.0" text="Antidiabetic drugs oral agents" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="72:89" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.e.4" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="36-43" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.e.1" text="insulin" type="Drug"/></anaphoraRelation><entity charOffset="0:18|20:31" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.e.0" text="Antidiabetic drugs oral agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="Antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="36:43" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.e.1" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="47:64" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.e.2" text="dosage adjustment" type="Caution_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.181" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.181.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182" text="Alcohol, barbiturates, or narcotics   potentiation of orthostatic hypotension may occur."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183.e.4"/></sentence><sentence biomedicalEntities="1" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.184" lineNumber="177" text="Other antihypertensive drugs   additive effect or potentiation." type="irregular"><entity charOffset="6:28" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.184.e.0" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="Other antihypertensive drugs   additive effect" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="31:62" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.184.e.1" text="additive effect or potentiation" type="Increase_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.184.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.184.e.1"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.184.e.0"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.181" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.181.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.182" text="Alcohol, barbiturates, or narcotics   potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.183" text="Antidiabetic drugs (oral agents and insulin)   dosage adjustment of the antidiabetic drug may be required."/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.185" text="Cholestyramine and colestipol resins   Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. " type="negative"><entity charOffset="19:29" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.185.e.0" text="colestipol" type="Biomedical_Entity"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins   Absorption of hydrochlorothiazide" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="53:72" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.185.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="colestipol resins   Absorption of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:14" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.185.e.2" text="cholestyramine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008402" phraseText="Cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.185.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.185.e.1"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.185.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.185.e.0"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.185.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.185.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186" lineNumber="179" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively." type="regular"><anaphoraRelation><anaphoraEntity charOffset="99:102" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.5" text="its" type="Expression"/><antecedentEntity charOffset="68-87" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.4" text="hydrochlorothiazide" type="Drug"/></anaphoraRelation><entity charOffset="23:37" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.0" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="Single doses of either cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="41:58" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.1" text="colestipol resins" type="Drug_Class"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="92:98|103:145" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.2" text="reduce absorption from the gastrointestinal tract" type="Decrease_Interaction"/><entity charOffset="68:87" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.4" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.5" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.2" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.5" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.2" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187" lineNumber="181" text="Corticosteroids, ACTH   intensified electrolyte depletion, particularly hypokalemia." type="irregular"><entity charOffset="24:57" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.0" text="intensified electrolyte depletion" type="Specific_Interaction"/><entity charOffset="72:83" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.2" text="hypokalemia" type="Specific_Interaction"/><entity charOffset="0:15" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.4" text="Corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="Corticosteroids," preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="17:21" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.5" text="ACTH" type="Drug"><Normalization><RxNorm RxCui="376"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.5"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.4"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.ddi.2"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.5"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.4"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.4" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188" lineNumber="183" text="Pressor amines (e.g., norepinephrine)   possible decreased response to pressor amines but not sufficient to preclude their use." type="irregular"><entity charOffset="0:14" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188.e.0" text="Pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="Pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><entity charOffset="22:36" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188.e.1" text="norepinephrine" type="Drug"><Normalization><mmtx cui="C0028351" phraseText="norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="49:67" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188.e.3" text="decreased response" type="Decrease_Interaction"/><entity charOffset="71:85" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188.e.5" text="pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="possible decreased response to pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><drugClassMembership drug="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188.e.1" drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188.e.0"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188.e.3"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.4"/></ellipsisSentence><middleSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187" text="Corticosteroids, ACTH   intensified electrolyte depletion, particularly hypokalemia."/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188.e.5"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189" lineNumber="185" text="Skeletal muscle relaxants, nondepolarizing (e.g., tubocurarine)   possible increased responsiveness to the muscle relaxant." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="107:122" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189.e.3" text="muscle relaxant" type="Expression"/><antecedentEntity charOffset="0-42" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189.e.0" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"/></anaphoraRelation><entity charOffset="0:42" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189.e.0" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"><Normalization><mmtx cui="C0037250" phraseText="Skeletal muscle relaxants," preferredWord="skeletal muscle relaxants" semType="phsu"/><RxNorm RxCui="1427638"/></Normalization></entity><entity charOffset="50:62" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189.e.1" text="tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="tubocurarine" preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="75:99" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189.e.5" text="increased responsiveness" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189.e.1" drugClass="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189.e.0"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189.e.5"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.186.e.4"/></ellipsisSentence><middleSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.187" text="Corticosteroids, ACTH   intensified electrolyte depletion, particularly hypokalemia."/><middleSentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.188" text="Pressor amines (e.g., norepinephrine)   possible decreased response to pressor amines but not sufficient to preclude their use."/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.189.e.3"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190" lineNumber="187" text="Lithium   should not generally be given with diuretics. " type="regular"><entity charOffset="45:54" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190.e.0" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="given with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="17:39" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190.e.1" text="not generally be given" type="Caution_Interaction"/><entity charOffset="0:7" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190.e.3" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190.e.1"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190.e.3" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190.e.0" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.190.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191" lineNumber="187" text="Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity. " type="regular"><entity charOffset="0:15" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.0" text="Diuretic agents" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic agents" preferredWord="Diuretics" semType="phsu"/><mmtx cui="C1254351" phraseText="Diuretic agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="16:42" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.1" text="reduce the renal clearance" type="Increase_Interaction"/><entity charOffset="85:93" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.3" text="toxicity" type="Increase_Interaction"/><entity charOffset="77:84" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.5" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="a high risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="46:53" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the renal clearance of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.1"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.ddi.2"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.3"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.6" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.5" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.191.e.3" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192" lineNumber="187" text="Refer to the package insert for lithium preparations before use of such preparations with VASERETIC." type="regular"><entity charOffset="0:27" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192.e.0" text="Refer to the package insert" type="Caution_Interaction"/><entity charOffset="32:52" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192.e.2" text="lithium preparations" type="Drug_Class"><Normalization><mmtx cui="C0023870" phraseText="for lithium preparations" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="90:99" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192.e.3" text="VASERETIC" type="Drug"><Normalization><mmtx cui="C0633761" phraseText="with VASERETIC." preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192.e.2" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192.e.3" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.192.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193" lineNumber="189" text="Non-steroidal Anti-inflammatory Drugs   In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. " type="regular"><entity charOffset="218:236" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="82:119" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.1" text="non-steroidal anti-inflammatory agent" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><mmtx cui="C3536840" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="124:143|179:186" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.2" text="reduce the diuretic effects" type="Specific_Interaction"/><entity charOffset="124:134|162:186" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.4" text="reduce the antihypertensive effects" type="Specific_Interaction"/><entity charOffset="124:134|145:156|179:186" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.6" text="reduce the natriuretic effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.2"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.ddi.2"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.4"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.ddi.3"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.6"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.0" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.193.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194" lineNumber="189" text="Therefore, when VASERETIC and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained." type="regular"><entity charOffset="16:25" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194.e.0" text="VASERETIC" type="Drug"><Normalization><mmtx cui="C0633761" phraseText="VASERETIC" preferredWord="Vaseretic" semType="phsu, orch"/><RxNorm RxCui="175128"/></Normalization></entity><entity charOffset="30:68" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194.e.1" text="non-steroidal anti-inflammatory agents" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="non-steroidal anti-inflammatory agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="115:123" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194.e.2" text="observed" type="Caution_Interaction"/><drugInteraction id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194.ddi.1"><interaction trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194.e.2"><relations><relation type="hasObject"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194.e.1" trigger="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.194.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.196" text="Enalapril in combination with hydrochlorothiazide was not mutagenic in the Ames microbial mutagen test with or without metabolic activation. " type="negative"><entity charOffset="30:49" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.196.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.196.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="Enalapril in combination" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.196.e.1" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.196.e.0"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.203" text="There were no adverse effects on reproductive performance of male and female rats treated with up to 90 mg/kg/day of enalapril (26 times the MRHDD when compared on a body surface area basis)." type="negative"><entity charOffset="117:126" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.203.e.0" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="of enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="184:189" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.203.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="compared on a body surface area basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.203.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.203.e.1"/></sentence><sentence id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.205" text="Two year feeding studies in mice and rats conducted under the auspices of the National Toxicology Program (NTP) uncovered no evidence of a carcinogenic potential of hydrochlorothiazide in female mice at doses up to approximately 600 mg/kg/day (53 times the MRHDD when compared on a body surface area basis) or in male and female rats at doses up to approximately 100 mg/kg/day (18 times the MRHDD when compared on a body surface area basis). " type="negative"><entity charOffset="165:184" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.205.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="no evidence of a carcinogenic potential of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="434:439" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.205.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="compared on a body surface area basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="300:305" id="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.205.e.2" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="compared on a body surface area basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.205.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.205.e.1"/><pair ddi="false" e1="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.205.e.0" e2="Dailymed.bf3007e2-8fcc-48de-8fd5-55e95033d62f.s.205.e.2"/></sentence><positiveExamples number="45"/><negativeExamples number="82"/></document>